|
Friday
June 29, 2001
•
MDS
Proteomics and Abgenix Announce Exclusive Agreement to Develop
Proteomic-Based Antibody Therapies
•
4,000
Drug Discovery Scientists and Business Leaders to Convene in Boston for
Drug Discovery Technology 2001; Presentation topics include: Proteomics
and Protein Technologies
Thursday
June 28, 2001
•
Phylos
Announces New Proteomics Technology for Unraveling Disease-Causing Pathways
• Novel
Anti-Cancer Protein Discovered by Alfacell Scientists See
Patent (6,239,257: Family of proteins belonging to the pancreatic ribonuclease
a superfamily)
•
Incyte
and Lexicon Form Strategic Drug Discovery Alliance
•
Genomic
Solutions Supplies Research Instruments For Summer Course At Marine
Biological Laboratory
• BioInsights
Analyzes New Systems Biology Field
Wednesday
June 27, 2001
•
Vertex
Researchers Solve 3-D Atomic Structure of GSK3b Enzyme, Potential Target
for New Diabetes Treatments; Announces
the Date of its Q2 2001 Financial Results Conference Call and Webcast
• Myriad
Launches Predictive Medicine Testing in Germany, Switzerland and Austria
•
Genome
Technology Magazine Announces Venter and Landers the Winners of First
GT All-Stars Vote
• Varian
Receives First Order for World's Most Powerful NMR Spectrometer from Yokohama
City University
•
Biotech:
Desperate No More -TheStandard.com
• Cubist
Pharmaceuticals and Syrrx Announce Drug Discovery Collaboration
•
MediChem
CEO to Present at William Blair Conference
•
Data
Explosion Begs Question of How to Manage It -GenomeWeb.com
•
GPC
Biotech Achieves Milestones by Delivering Seven Anti-Microbial Targets
Tuesday
June 26, 2001
• Lilly
Sets up Systems Biology R&D Center in Singapore
•
MediChem and Neurocrine Biosciences Sign Proteomics Agreement
on GPCR Drug Target for Depression, Anxiety
•
LSBC
Adds to its Scientific Advisory Board
•
Biotechies
Swarm Into San Diego: Now that the genome has been mapped, a conference
of 12,000 wonders how to make money from it -TheStandard.com
•
Myriad
Chooses Sun to Provide Computing Power for Protein Mapping Venture
-GenomeWeb.com
• Yamanouchi
signs database pact with Celera
•
European
Bioinformatics Institute Supports LabBook's BSML Format
Monday
June 25, 2001
•
Ciphergen Announces Collaboration With Invitrogen ;Announces
Acquisition of BioSepra from Invitrogen, Expands Proteomics Business
in Protein Purification
•
SYN
X Pharma warrants exercised in full by Genzyme Corporation
• Caprion,
Sun, Oracle and CGI Collaborate to Power Proteomics
Effort
•
IBM's
Biotech Resurgence -Forbes.com
• Yamanouchi
Pharmaceutical Co. to Utilize Celera Discovery System
• Biotech
Is Delivering ... and This Is Only the Beginning -Burrill & Company
• Bruker
AXS Appoints of Former Agilent Senior VP to Board
•
Human
Proteome Organization (HUPO) Appoints First President -GenomeWeb.com
•
3-Dimensional
Pharmaceuticals to Present at BIO 2001
Friday
June 22, 2001
•
Ontario
Commercial Court Rules in Favour of SynX Pharma in Dispute with
Genzyme
•
MDS
Inc. Adds Pharma Executive to Board
Thursday
June 21, 2001
• Proteomics
Streamlining Drug Discovery Efforts
•
Luminex
Corporation to Present at First Union Securities' Nantucket Conference
• Proteome
Society Launches Online Forum: 4-year-old Science-Based Organization Encourages
Global Collaboration Online
•
LSBC
Hires Corporate Development Team to Bring in Pharma Partners, Shore Up
Finances -GenomeWeb.com
•
MDS
Proteomics is Ready for Big Pharma, Executive Says -GenomeWeb.com
•
Seeing
Into Biology's Future -Wired.com
Wednesday
June 20, 2001
•
Proteome
Systems and U Missouri in a Cancer Proteomics Collaboration
•
New
U.S. Patent Strengthens Phylos' Proprietary Position Around its
Profusion™ Technology Platform See
Patent (6,194,550: Systematic polypeptide evolution by reverse translation)
•
Protein
Researchers Get New Tools -Wired.com
•
Bayer
and CuraGen Identify 12 Novel Drug Targets Linked With Obesity
and Diabetes
• LSBC
and Plant Bioscience Ltd. Announce an Exclusive Licensing Agreement
in Plant Functional Genomics
•
OGS
and NeoGenesis Announce High-Throughput, 'Target-to-Drug Lead'
Collaboration
• Compugen
Announces Two New Advancements in Proteomics: ProtoCall™ Mass Spectrometry
Engine and Z3 Version 2.0 2D-Gel Analysis System
•
Boston
Biomedica Awarded US Patent for Use of Pressure Cycling Technology
(PCT) in Nucleic Acid and Protein Sequencing See
Patent (6,245,506: Integrated Sequencing Device)
• BioTrove
Announces Advanced Technology Program Award from N.I.S.T. for Massively
Parallel Screening
• Genteric
Announces Broad Patent Coverage for Its Gene Pill Platform Company Given
Notice of Allowance by U.S. Patent & Trademark Office for All Secreted
Proteins See
Patent (6,225,290: Systemic Gene Therapy By Intestinal Cell Transformation)
• Luminex
adopts stockholder rights plan
•
Vertex
Announces New VP, Regulatory Affairs
•
Human
Genome Sciences Breaks Ground for New R&D and Corporate Campus, to
include Proteomics Facilities
Tuesday
June 19, 2001
•
Thermo
Finnigan and New Objective Team Up to Simplify Nanospray for Proteomics
•
Proteins
Are Back To Confuse Investors -Forbes.com
•
Xencor Receives SBIR Phase II Grant for High Throughput Screening
of Novel Computationally Derived Optimized Protein Sequences
•
Waters
Corp. shares turned to ice
•
MDS
Inc. Normal Course Issuer Bid
Monday
June 18, 2001
• CHI:
Beyond Genome 2001: Proteomics, Begins This Week
•
Marconi,
OGS Invest $21 Million in Joint Venture -WallStreetJounal.com
• Cellular
Genomics Selects Viaken Systems and InforMax as Partners
For the Implementation of a GenoMax-based Bioinformatics Platform
• State
of Wisconsin Investment Board Agrees to Purchase an Additional $8.19 Million
in Cytogen Common Stock
•
Thermo
Finnigan Launches New Modular Surveyor™ HPLC System for the Research
Laboratory Market
• Boston
Life Sciences Successfully Scales-Up GMP Manufacturing of It's Anti-Angiogenic
Protein for Use in Humans
•
Aptagen
Launches Protein Genesis™ Molecular Evolution Platform
• AlphaGene
& Questar Join Forces to Accelerate Drug Target Identification
•
Interlocking
a Proteomics Target Finding and Validation Machinery With The Industrialized
Drug Discovery Process: Evotec OAI and MelTec Form Joint
Venture
•
LION
Bioscience Launches SCOUT™ Software for Molecular Network Analysis
Friday
June 15, 2001
•
OGS
Building 'Protein Atlas' to Provide First Definitive List and Structure
of Human Protein-Coding Genes
• Former
Upjohn Executive Appointed to MDS Proteomics' Board
• Gene
Machines (IBM's Blue Gene, Compaq's Red Storm) -TheStandard.com
• Celera
Signs DNA Sciences to Database Subscription Deal
Thursday
June 14, 2001
•
3-Dimensional
Pharmaceuticals Receives $1 Million Phase II SBIR Grant from NIH
•
Biotechnology
and Information Technology Join to Speed Drug Discovery at BIO 2001
•
Protein
Kinases in Drug Discovery & Development Conference to Feature Latest Findings
in Princeton, NJ, October 15-16, 2001
Wednesday
June 13, 2001
•
MediChem
Awarded Phase II SBIR Grant for Automated Technologies In Structural Proteomics
• BD
Biosciences and Dyax Corp. Announce Research Products and Proteomics
Alliance
• Galapagos
Genomics and Bayer Announce Functional Genomics Collaboration
in Asthma Research
•
U.S.
Genomics Receives First U.S. Patent for Molecular Motors See
Patent (6,210,896: Molecular Motors)
•
Francis
S. Collins and J. Craig Venter to be Honored at The BIO 2001
• Microarray
Biochip Market Estimated to Grow to $1 Billion by 2005!
• NCGR
Releases ISYS™: New Software to Integrate Bioinformatic Tools, Databases
Tuesday
June 12, 2001
•
Aurora
Biosciences Announces Completion of the Ultra-High Throughput Screening
System (UHTSS® Platform) for Merck
•
Take
a Look at Technologies and Business Plans From 234 Biotech Companies;
BIO 2001 to Hold Third Annual International Investor & Partnering Forum
•
Viron
Therapeutics Licenses Novel Anti-Inflammatory Protein to Xenova
Group PLC
•
New
Drug Delivery Technologies To Be Presented at IBC's Protein and Peptide
Drug Delivery Conference September 19-20, 2001 San Francisco, Ca.
• IBM
Exec: Biotech IT Services Should Reach $40 Billion By 2004
•
Tularik
Granted U.S. Patents For Novel Human Kinases
Monday
June 11, 2001
•
Cellular Genomics Awarded
U.S. Patent for Integral Membrane Protein-Protein Interaction/Pathway
Mapping Technology See
Patent (US6,242,205: Method of Detecting Drug-Receptor and Protein-Protein
Interactions)
•
Gene
Expression Microarrays to be Presented by Merck & Incyte
at Microarray Technologies Summit Sept 24-25 in Princeton
•
AlphaGene
Discovers (3) Novel Human Cell Receptors Involved in Insulin Metabolism
•
Astex
Technology joins Global Phasing consortium to collaborate on macromolecular
crystal structure determination projects
• Expanding
Biochip Applications Promise Payoff for Life Science and Drug Discovery
Companies, Says Frost & Sullivan
•
GlaxoSmithKline
executive joins SYN X Pharma as COO
•
Genetix
Group plc Launches New Proteomics Tool, the gelPix System
•
Medarex
and Sangamo BioSciences Announce Collaboration To Discover and
Develop Therapeutic Antibodies to G-Protein Coupled Receptors
Friday
June 8, 2001
•
Beyond
Genomics Names VP of Bioinformatics
•
Cytogen
(Axcell) Announces Senior Management Promotions
•
Vertex
and Aurora Biosciences Announce Registration Statement for their
Proposed Merger Declared Effective by the SEC
•
X-ray
Vision in Structural Genomics: Scientists develop high-throughput methods
for X-ray crystallographic protein structure determination -TheScientist
•
Genome
Economy: With fewer human genes than expected, where do all those proteins
get their instructions? -TheScientist
•
How
to Build a Proteomics Company -GenomeWeb
Thursday
June 7, 2001
•
Proteomics:
Beyond the Genome -BusinessWeek Online
•
Proteomics
Industry Forecasted at Nearly $3 Billion by 2005
•
New
Functional Proteomics Market Holds Potential for Huge Growth in Coming
Years -BioInsights Buy
Report (Functional Proteomics: Short-Cuts to Drug Discovery)
• Bruker
Daltonics, Applied Biosystems and Indiana University
Cross License Significant Mass Spectrometry Patents Related to MALDI-TOF
•
Thermo
Electron to Present at Goldman, Sachs & Co. 22nd Annual Healthcare
Conference
•
Biochips
Enabling Rapid Protein Discovery & Analysis to Be Featured At Microarray
Technologies Meeting Sept. 24-25 in Princeton, NJ
•
ISSYS
Inc. Receives $2.75 Million in Funding To Commercialize Advanced Micromachined
Biofluidic Chips
• MediChem and Elitra Pharmaceuticals Enter into Joint
Research Collaboration
•
Q&A:
George Stafford, Mass Spec Visionary, Discusses Evolution of Ion Trap
Technology -GenomeWeb
Wednesday
June 6, 2001
• Two
Texas Universities boost cutting-edge exploration into cellular function
with Amersham Pharmacia Biotech's proteomics technologies
•
GPC Biotech Expands
Boston Operation by Move to Larger Facility In Waltham, MA
•
Structural
GenomiX Publishes the Three Dimensional Structure of a Key Protein
Involved in Bacterial Pathogenesis
• Phylos Receives
Key U.S. Patent For its Profusion™ Technology Platform See
Patent (Libraries of protein encoding RNA-protein fusions)
•
Invitrogen
Launches Revolutionary Molecular Biology Platform for Proteomic Studies
•
Packard
BioScience Launches its SpotArray™ Enterprise Microarray Production
System
•
Exelixis
Announces First-Ever 'Functional Map' Linking Genes to Biological Activity
in a Vertebrate
•
Luminex
Announces Strategic Partnership With R&D Systems including LabMAP™
•
LSBC
Announces Results of Landmark Index of Human Proteins and Program to Create
First Protein Chips
• Blackstone
Technology Group Receives $12.6 Million in Funding for High-Throughput
Computing Solutions
• Nymox
Pharmaceutical announces Protein linked with Alzheimer's Disease
• Vertex
Pipeline Will Support Development, Despite Risk
• Bristol-Myers
Squibb Completes Purchase of Seven 3DP ThermoFluor® `Any Target'
High-Throughput Screening Workstations
Tuesday
June 5, 2001
•
Cambridge
Antibody Technology and Xerion Pharmaceuticals Announce Licensing
Agreement for Human Antibody Technology
• Myriad
Discovers High Cholesterol Gene : CHD2 Enzyme is in Novel Pathway, May
Lead to New Class of Cholesterol Lowering Drugs
•
Microarray
Technologies Summit & Exposition to be Held September 24-25 in Princeton
Monday
June 4, 2001
•
LSBC to Announce Landmark Completion of Comprehensive Index of Human
Proteins at New York Academy of Sciences
•
Matrix
Science Announces an OEM Agreement with Applied Biosystems
to Distribute MASCOT™ Software for Mass Spectrometry-Based Protein
Identification
•
CHI
Report: Bioinformatics Activity Is Surging
Friday
June 1, 2001
•
U.S.
Bancorp Piper Jaffray Sees the Proteomic Industry as the Next Key Growth
Sector Within Biopharmaceuticals [Piper
Jaffray site]
•
Proteomic
Advances Headlines New Genomic Technologies Conference & Exposition in
Princeton, NJ, July 16-18, 2001
•
InforMax
Announces Availability of Two New GenoMax(TM) Modules With System 3.1
Release Including AxCell's ProChart™ Leading-Edge Proteomic
Application
• ARIAD
Announces Results of 3-Year Primate Study of Regulated Protein Therapy
to Treat Anemia
Thursday
May 31, 2001
• Gyros
AB and Affibody AB Announce Strategic Alliance to Develop the
World's First Microfluidics Based Protein Microarray Platform
•
Triad
Therapeutics Announces New Technique to Expand Application of NMR
For Structural Characterization of Large Proteins
•
Motorola
Bails Out of Deal with Molecular Staging -GenomeWeb
Wednesday
May 30, 2001
•
IBM,
MDS Proteomics team up on free biotech research database
• Science
and Technology Leaders Launch blueprint WORLDWIDE INC, Giving Researchers
Unprecedented Access to Vital Biomolecular Interaction Data
•
IBM
and Others Are Financing A Public Database on Proteins -Wall Street
Journal
• IBM
Wants to Play Doctor -TheStandard.com
•
Canadian
Non-Profit to Take Over BIND Protein Database -GenomeWeb
Tuesday
May 29, 2001
• MDS
Proteomics and IBM Life Sciences To Unveil BluePrint, a the
World's First Public Comprehensive Biomolecular Database
•
PerkinElmer
and MDS Sciex to Develop Next Generation TOF Mass Spectrometry
Solutions for Proteomics
• Bruker
Daltonics Introduces Suite of New Proteomics Products at ASMS
• Ciphergen
Announces New Product Offerings in ProteinChip® Proteomics
•
HTS
Biosystems Establishes Operations In Asia
•
SYN
X Pharma Awarded U.S. Patent for Stroke Diagnostic Test
•
Strong
Demand, Innovative Tools Drive Microarrays Market Growth, According to
Cambridge Healthtech Institute Report
•
Tm
Bioscience reports first quarter 2001 financial results (Luminex Agreement)
•
Genomic
Solutions introduces the GeneTAC™ UC-4 Microarray Imaging System
•
Molecular
Staging Inc. Announces a Number of Recent Additions to Its Senior
Management Team
•
Micromass
and Bio-Rad Sell Proteomics Platform to EMBL
-GenomeWeb
Friday
May 25, 2001
• 49th
Annual American Society for Mass Spectrometry (ASMS) Conference from May
27-31, in Chicago
• Applied
Biosystems Scientific Conference Call Scheduled for Tuesday, May 29
Thursday
May 24, 2001
•
Lynx
Closes $11 Million Private Equity Financing
• Phylos
Receives First U.S. Patent For Use of Its Profusion™ Technology and
a Method to Create Protein Arrays for High-Throughput Protein Profiling
See
Patent (Selection of proteins using RNA-protein fusions)
•
ActivX
Biosciences Appoints Vice President Of Chemistry
•
Vertex
to Webcast its Third Annual Investor Day
•
Luminex
Meets First Milestone in Tm Bioscience Agreement
Wednesday
May 23, 2001
•
American
Society for Mass Spectrometry to Honor Thermo Electron Director
of Research for Work in Ion Trap Mass Spectrometry
•
Genomics
One And WITA Proteomics Enter Into a Marketing Alliance
• Myriad
Sponsors AMA Launch of Hereditary Cancer Education Program
• Molecular
Mining Corp. Raises Over $8 Million in Second Round of Financing
Tuesday
May 22, 2001
•
Hybrigenics
and Institut Curie Open Joint Lab for Cancer Functional Proteomics
Research
•
GPC
Biotech Announces Successful Course of Business for 2001;
GPC
Biotech Q1 loss narrows, stock jumps
•
Curagen
CEO to sell 800,000 shares
• IBM
Exec: Chasing the Genome Gold Rush by Selling Biotech IT
•
MediChem
CEO Looks to Expand Proteomics Effort -GenomeWeb
•
Agilent,
MDS Proteomics to Collaborate on Protein Analysis Technology
-GenomeWeb
Monday
May 21, 2001
• European
Patent Office Revokes Thermo Finnigan's Ion Trap Mass Spectrometry
Patent See
Patent (EP202943B1:Method of operating an ion trap)
•
Robertson
Stephens Raises Rating of Vertex
Friday
May 18, 2001
•
Report
Analyzes Market Potential of Companies including Celera, Lynx
and Myriad
•
Pharma,
Computer Execs Gather to Discuss Supporting Harvard's cDNA Repository
(Institute of Proteomics) -GenomeWeb
Thursday
May 17, 2001
•
Genomic
Solutions introduces integrated digestion and spotting system for
proteomics
•
Cytogen
(AxCell) to Present at the UBS Warburg Global Specialty Pharmaceutical
Conference on May 23
•
GSAS
Harvard Biotechnology Club Announces a Proteomics Corp. as the Winner
of the Biotechnology Business Plan Competition
•
Packard
BioScience Receives New Patent for Imaging and Analysis Of Microarray
Biochips
• MediChem
Announces Results of Shareholder Meeting; Receives Technology Challenge
Grant and Two U.S. Patents
•
Proteomics
Expert Says Technology Lags Corporate Promises -GenomeWeb
Wednesday
May 16, 2001
•
Bruker Daltonics Appoints New CFO and VP
•
GPC
Biotech Appoints Senior VP of Drug Development
• InforMax Announces Genomax License Agreement With Cellular
Genomics, Inc.
•
European
Bioinformatics Institute to Receive Record Funding Increase from EC
-GenomeWeb
Tuesday
May 15, 2001
•
Integrative
Proteomics Completes First Pass Interrogation of the Proteome of Staphylococcus,
a Major Disease Bacterium; Announce Investment of Bruker and Aurora
•
Beyond
Genomics Forms Alzheimer's Disease Joint Venture with Elan Corporation
•
Lynx
and Hybrigenics Discover Novel Obesity Drug Target Candidate -
Companies File Joint Patent and Extend Agreement
• Myriad
Awarded Three U.S. Patents and Eight International Patents
•
No
More Business as Usual for Public Structural Genomics Effort, Rockefeller
Scientist Says -GenomeWeb
Monday
May 14, 2001
•
Caliper
is Added to the Nasdaq Biotechnology Index
•
InforMax
Announces License Agreement With Cellular Genomics, Inc.
•
MediChem
Moves ThermoGen Protein Expression and Biocatalysis Unit to Woodridge
Discovery Center
•
NIGMS Creates New Center for Bioinformatics and Computational Biology
-GenomeWeb
Friday
May 11, 2001
•
Merck
sees future deals on scale of Rosetta
•
Merck
Snags Rosetta -- Who's Next? -The Motley Fool
Thursday
May 10, 2001
•
Breakthrough Demonstrates Principles Behind Institute for Systems Biology,
Opens Door for Revolutionary Approach to Medical Research ; Institute
for Systems Biology Scientists Have Their Work Cut Out -GenomeWeb
Wednesday
May 9, 2001
•
Incyte
and Odyssey Pharmaceuticals Announce Collaboration To Functionally
Characterize Human Proteins
•
Luminex
CEO to Speak at Informed Investors Beltway Genomics Stocks Forum
•
Biacore
Interim Report January-March 2001; Annual
General Meeting in Biacore International AB
•
Myriad
Reports Reduced Loss for Q3 of Fiscal 2001; CEO
Talks to The Wall Street Transcript; Myriad
quarterly loss narrows
•
Discovery
Partners International Completes Acquisition of Xenometrix
• Harvard
Bioscience Announces Collaboration with NextGen in Proteomics
•
Compaq
Rustles Up Business Down Under -GenomeWeb
•
Ribozyme
Pharmaceuticals and Archemix Enter Into a Proteomics Alliance
Tuesday
May 8, 2001
•
Vertex
Reports Results of Annual Meeting of Shareholders ; Enters
Into Gene Function Collaboration with Deltagen
•
CuraGen Discovers Novel Growth Factor in PDGF Family
•
Lynx
and AniGenics Enter Collaboration
Monday
May 7, 2001
• Bruker
Daltonics Q1 2001 Product Revenue Increases 55%; Bruker
AXS Appoints New CFO
•
Thermo Electron
to Present at Deutsche Banc Alex. Brown Conference
•
BioVisioN and Applied Biosystems Form Collaboration, Launch
European Laboratory for Proteomics
•
Ciphergen
Announces Protein Expression Profiling Patent Issuance See
Patent (US6225047:Use of retentate chromatography to generate difference
maps )
• Ciphergen
CEO talks to The Wall Street Transcript
•
Genomic,
Proteomic, Biotech Valuation & Investment Prospects to Be Featured at
June 4-5 Pharma Partnering Conference
•
Incyte
and Genomic Health Announce Collaboration
•
Deutsche
Banc Alex. Brown Hosts Its 26th Annual Health Care Conference from May
8-10 in Baltimore, MD
•
Protein Chip Company, Molecular Reflections, Raises $14M -GenomeWeb
Friday
May 4, 2001
• LSBC
Adopts Stockholder Rights Plan
•
Myriad
to be Broadcast On Vcall Over the Internet
• Applied
Biosystems Predicts Slower Growths Short Term
•
Proteome
Systems, Sigma-Aldrich in Manufacturing and Distribution Deal
-GenomeWeb
Thursday
May 3, 2001
•
CuraGen
to Webcast Presentation at Life Sciences Conference
• Molecular
Mining Corporation to Co-Sponsor In Silico Technologies in Drug Discovery
Conference
•
Thermo
Electron Adds Vice President of Marketing
• Analyst
Expects an Unparralled Product Wave from Proteomics
•
Harvard
Proteomics Institute Seeks $100M-GenomeWeb
Wednesday
May 2, 2001
•
Large
Scale Biology Media Advisory - Landmark Completion of Comprehensive
Index of Human Proteins to be Presented at New York Academy of Sciences
• Large Scale Biology Reports Q1 2001 Financial Results
• Bruker
Daltonics to Webcast Q1 Conference Call on May 8, 2001
•
Genomic
Solutions Announces Licensing Agreement And Equity Investment in Optical
Biochip Company
•
Genicon
Sciences Secures $27 Million in Equity Financing to Continue Penetration
of Genomic and Proteomic Research Market
•
Sun's
High Performance Computing Solutions Power Oxford GlycoSciences
Efforts In Proteomics
•
Bayer
AG - CuraGen Drug Discovery & Pharmacogenomic Alliance to be
Presented At Pharma & Biotech Licensing Conference on June 4-5 in Philadelphia
•
Myriad
Financial Update Conference Call
•
Biotech
Startups Defy VC Doldrums (Structural GenomiX, Signature Bioscience
Inc. mentioned) - The Daily Deal
Tuesday
May 1, 2001
•
MediChem
Announces Record Q1 2001 Revenues
•
Myriad
Drug Enters Preclinical Testing for Prevention of Acute Thrombosis
•
Bio-Rad
Announces Record Q1 2001 Sales Partly Based on Increased Sales of ProteomeWorks
•
Ciphergen
Reports Q1 2001 Financial Results
•
InforMax
Announces New CSO; and
New Sales VPs
•
InforMax
and AxCell to Host European Seminar Series: 'High-Throughput Research:
Integrating Genomics, Expression, and Proteomics for Accelerated Discovery
Research'
Monday
April 30, 2001
•
Vertex
to Acquire Aurora Biosciences
•
Vertex
Agrees to Acquire Aurora In $538 Million All-Stock Deal -Wall
Street Journal
• Structural
Bioinformatics Doubles the Size of Its ProMax Protein Structure Database
•
Caliper
Announces Q1 2001 Financial Results
•
Anvil
Informatics Expands Its Management Team
• Compugen
Reports Q1 Financial Results
Friday
April 27, 2001
•
Wanted: Hot Industry Seeks SuperGeeks
To build better drugs, the exploding field of bioinformatics is looking
for highly trained workers comfortable with supercomputing and biology
- Newsweek
• Genomic
Solutions Dedicates Senior Management Function to PerkinElmer
Relationship
• Luminex
Presenting at Informed Investors Beltway Genomics Stocks Forum May 19
•
Proteomics
to Headline New Genomic Technologies Conference & Exposition In Princeton,
NJ, July 16-18, 2001
•
InforMax
Q1 2001 Financial Results Conference Call
•
Experts
Question Value of Myriad's Proteome Mapping Strategy -GenomeWeb
•
Biacore's Patent U.S. 5,436,161 Infringed by Thermo Bioanalysis;
$1.7M in Damages See
Patent (US5436161:Matrix coating for sensing surfaces capable of selective
biomolecular interactions, to be used in biosensor systems)
Thursday
April 26, 2001
•
GeneProt
Announces the Opening of the World's First Large-Scale Proteomic Discovery
Center
•
Cytogen
Reports Q1 2001 Results; Product Sales Up 25% Over Last Quarter
•
Francis
Collins and Craig Venter are Featured Speakers of BIO 2001
•
Lifecodes
to Develop HLA Applications on Luminex Technology
•
Myriad
Genetics Reports Phase II Data on Lead Compound
•
CuraGen
Reports Q1 2001 Financial Results
•
So
Far, Millennium Is Missing Its Milestones -BusinessWeek
Online
•
Syrrx
Hires New CFO -GenomeWeb
•
NetGenics To Resell IBM DiscoveryLink Technology
• Applera
sees revived Applied Biosystems growth in 2002 ; Celera
Loss Widens But Revenues Rise
Wednesday
April 25, 2001
•
DECODON
Releases Version 1.1 of its 2D Gel Analysis Software Delta2D
•
Bio-Rad
Q1 Financial Results Conference Call
•
Incyte
Reports Financial Results for First Quarter of Fiscal 2001 Revenues Up
25%
•
Ciphergen
Conference Call and Webcast
•
Aurora
Biosciences Announces Webcast Conference Call Of Q1 2001 Financial
Results
•
Biomax
Informatics AG Launches Version 4.0 of the BioRS Integration and Retrieval
System
•
Genomic
Solutions Signs License Agreement with Louisville Research Foundation
•
Lynx
Reports Financial Results for Q1 2001
Tuesday
April 24, 2001
•
New
Proteomics Database Identifying Protein Interactions in the Human Body
Introduced in Europe by AxCell Biosciences and InforMax
•
Vertex
Pharmaceuticals Reports Q1 2001 Financial Results
•
New
D&MD Report -- Bioinformatics
•
DoubleTwist
and Yeda of the Weizmann Institute of Science Announce Exclusive
Agreement
•
Triad
Therapeutics Combines Structural Proteomics and Smart Chemistry To
Accelerate Small Molecule Drug Discovery From Years to Weeks
•
Genomics
Technologies Key to Improving Drug Development Process - Accenture
-GenomeWeb
•
Micromass,
Spotfire in Deal to Link Proteomics Analysis Tools -GenomeWeb
Monday
April 23, 2001
•
DoubleTwist
Announces Availability of Annotated Human and Mouse Gene Index Databases
on DoubleTwist.com
•
Applied
Biosystems Obtains an Exclusive License to Northeastern University
Technology for Proteomics and Biomolecular Analysis
•
Cognia
Forms Foundation of Scientific Advisory Board
•
U.S.
District Court in Boston Rules that Bruker Daltonics Does Not Infringe
Thermo Finnigan's Key Ion Trap Patent See
Patent (US4540884:Method of mass analyzing a sample by use of a quadrupole
ion trap)
•
LumiCyte
Cancer Biology Fellowship' Program Launched: Taking Proteomics Beyond
the Laboratory
•
Lynx
Invites You to Participate in Q1 2001 Conference Call
Friday
April 20, 2001
•
Thermo Electron to Sell Modified Ion Trap Mass Spectrometers in Germany
•
Cognia Awarded NIGMS Grant to Build Protein Catabolism Database
- GenomeWeb
Thursday
April 19, 2001
•
Genomic
Solutions and PerkinElmer Lawsuit Settlement Includes Termination
of Call Option; Reports
Increased Revenue, Strengthens Distribution Relationship With PerkinElmer;
Genomic
Solutions to Hold Conference Call April 24
•
Aurora
Biosciences and Integrative Proteomics Announce Strategic Alliance
And License Agreement for Drug Discovery Capabilities
•
Biosite
Diagnostics Inc. Reports Q1 2001 Results
Wednesday
April 18, 2001
•
Large Scale Biology and Icon Genetics Announce Identification of Gene
Sequences for Use in Commercial Plant Varieties
•
Leroy Hood, M.D., Ph.D., Joins Board of Omeros Medical Systems Inc.
•
Venture
Capitalists to Discuss Biotech, Information Technology & Investing
•
Novartis
- Vertex Drug Discovery Collaboration on Kinases to be Presented at
Pharma & Biotech Licensing Conference on June 4-5 in Philadelphia
Tuesday
April 17, 2001
•
Structural Proteomics Offers Keys to Accelerating Pharmaceutical R&D,
According to Cambridge Healthtech Institute Report Buy
Report
•
New Class of Synthetic Antibodies Are More Selective, More Potent
Than Natural Proteins
•
UCSC Extension Bioinformatics Certificate Program Wins Award for
Top Program
•
Molecular
Mining Corp. Ships MMC GeneLinker Gold Gene Expression Analysis Software
•
Applied Biosystems
Announces New Marketing and Product Development Organizations
•
IBM Research Team Finds New Scoring Function for Protein Structure
Prediction - GenomeWeb
Friday,
April 13, 2001
•
Proteomics Sector Shows First Symptoms of M&A Fever -GenomeWeb
Thursday,
April 12, 2001
• Bruker Daltonics Announces German District Court Ruling that
Thermo-Finnigan's GCQ and LCQ Ion Traps Infringe Bruker Daltonics
Patent
•
Incyte to Release Q1 Earnings on April 25
•
Zyomyx Enters Strategic Alliance and Joint Development Agreement with
Axon Instruments to Develop Protein Biochips Technologies
•
DoubleTwist Announces More Than 20 New Customers
Wednesday,
April 11, 2001
• Lynx and GenoMar Enter Marine Genomics Collaboration
•
Bruker AXS Acquires X-Ray Crystallography Company for Development
of Structural Proteomics Solutions
•
IBM, LabBook Team To Deliver Integrated, Standards-Based Data
Management Tools for Life Sciences
•
MediChem Enters into Structural Proteomics Agreement With Celgene
•
Ce lerent
to Provide Project Management and Implementation Services to Celera
•
Ciphergen Prepares to Step Up Chip Preparation and Analysis -GenomeWeb
Tuesday,
April 10, 2001
• Human Proteome Organisation (HUPO) Update
•
Galenica Pharmaceuticals Announces Research Agreement With the U of
Alabama
•
Biosite Diagnostics to Conduct Q1 Conference Call
•
Leroy Hood, Francis Collins and Eric Lander to speak at neurogenomics
conference
•
Frost & Sullivan reports estimates biochip market to reach $3.3 Billion
by 200 -GenomeWeb
Monday,
April 9, 2001
• GeneFormatics Names CTO and Key X-Ray Crystallography Advisor
•
Bruker Daltonics Reports First Quarter 2001 Bookings of New Life Science
Systems Orders
•
Cytogen Appoints Former Biotech Analyst as VP of Investor Relations
And Corporate Communications
•
Celera and Spotfire Partner To Integrate Products Will Link
DecisionSite and Celera Discovery System
•
CEO of Cellzome to speak at Harvard Biotech Club
Thursday,
April 5, 2001
• Oxford GlycoSciences and the Institute for Systems Biology
Announce ICAT based Proteomics Platform Alliance
•
Structural GenomiX
Acquires Prospect Genomics
•
Genomic Solutions, Pyrosequencing AB, and Transgenomic
begin a joint nationwide seminar series on proteomics
•
Incyte Genomics Appoints CEO of Extricity Software to Board of Directors
•
Researchers Look to Industrialize Structural Genomics -GenomeWeb
•
Structural Genomics Leaders Eye Patent Pitfalls-GenomeWeb
•
3 Companies Will Try to Identify All Human Proteins -NY Times
•
Structural Proteomics Meeting Raises Questions about Data Sharing
-GenomeWeb
•
Oracle Helps To Fund Protein Map -San Francisco Chronicle
Wednesday,
April 4, 2001
• Myriad Genetics, Hitachi and Oracle announced
the formation of Myriad Proteomics in a landmark alliance to map
the human proteome in less than three years
•
InforMax Expects to Exceed Consensus Q1 Revenue Estimates, and Report
a Higher Than Anticipated Loss Per Share
•
AxCell Biosciences Previews ProChart, Its Novel Proteomics Database
Product
•
Lynx Announces Gene Expression Analysis Deal With AstraZeneca
•
De Novo Pharmaceuticals Announces Deployment of Integrated Drug Design
Platform, Second Tranche of Investment
•
Hawkins Says Joint Genome Institute Gearing up for Proteomics
-GenomeWeb
| 
